Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Calcium acetate 1g tablets
0905022C0AAAAAA
|
Calcium acetate | Calcium acetate | Nutrition and Blood | 6,436 |
|
Calcium acetate 950mg tablets
0905022C0AAAEAE
|
Calcium acetate | Calcium acetate | Nutrition and Blood | 5,638 |
|
Calcium acetate 475mg tablets
0905022C0AAAFAF
|
Calcium acetate | Calcium acetate | Nutrition and Blood | 4,373 |
|
Renacet 950mg tablets
0905022C0BDAAAE
|
Renacet | Calcium acetate | Nutrition and Blood | 3,421 |
|
Renacet 475mg tablets
0905022C0BDABAF
|
Renacet | Calcium acetate | Nutrition and Blood | 3,167 |
|
Phosex 1g tablets
0905022C0BBAAAA
|
Phosex | Calcium acetate | Nutrition and Blood | 1,662 |
|
Calcium acetate 500mg tablets
0905022C0AAACAC
|
Calcium acetate | Calcium acetate | Nutrition and Blood | No data available |
|
Calcium acetate 660mg tablets
0905022C0AAAGAG
|
Calcium acetate | Calcium acetate | Nutrition and Blood | No data available |
|
Calcium acetate 667mg capsules
0905022C0AAADAD
|
Calcium acetate | Calcium acetate | Nutrition and Blood | No data available |
|
Everose 660mg tablets
0905022C0BEAAAG
|
Everose | Calcium acetate | Nutrition and Blood | No data available |
|
Phosex 500mg tablets
0905022C0BBABAC
|
Phosex | Calcium acetate | Nutrition and Blood | No data available |
|
PhosLo 667mg capsules
0905022C0BCABAD
|
Phoslo | Calcium acetate | Nutrition and Blood | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.